Synercid

Active Ingredient(s): Dalfopristin + Quinupristin
FDA Approved: * September 21, 1999
Pharm Company: * KING PHARMS
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Synercid Overview

Quinupristin/dalfopristin (pronunciation: kwi NYOO pris tin / dal FOE pris tin) (trade name Synercid) is a combination of two antibiotics used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium. Quinupristin and dalfopristin are both streptogramin antibiotics, derived from pristinamycin. Quinupristin is derived from pristinamycin IA; dalfopristin from pristinamycin IIA. They are combined in a weight-to-weight ratio of 30% quinupristin to 70% dalfopristin. ...

Read more Synercid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Quinupristin/dalfopristin

Recent Synercid Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dalfopristin + Quinupristin
  • Injection: 350mg/vial + 150mg/vial, 420mg/vial + 180mg/vial, 500mg, 600mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Synercid: (1 result)

Sorted by National Drug Code
  • 61570-260 Synercid Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc

Drugs with one or more similar ingredients: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA